-- Cancelled --  

Novel developments for treating brain disorders

In this EURON workshop different topics in relation to various emerging treatments for brain disorders will be presented. It builds upon our former bi‐annual workshop “Drugs and the Brain: from Laboratory to Clinic”, which received support from FENS/IBRO‐PERC several times. The adaptation of the course follows evolving neuroscientific insight. Indeed, while there is still a focus on pharmacological therapeutics, there is a surge in the development of alternative treatment strategies for a range of brain disorders, including (non‐invasive) brain stimulation approaches and nutrition interventions. In addition, it is now clear that the increasing burden of brain disorders can only be tackled by prioritizing prevention in health care policies. Therefore, this course deals with the neuroscience that underlies these novel treatments. We will focus here on the underlying neuroscientific concepts that have a broad range of applicability, but will discuss each concept using examples of specific brain disorders.

The set-up of the course is intended to encourage active participation of students and to stimulate interaction between experts and participants. After expert lectures in the morning, students will work on challenging problems or statements, present and discuss the outcome in a plenary meeting, during live-streamed Q&A sessions.To assure that participants are well prepared for the course (having a basic understanding of the principles of psychopharmacology), profit maximally from the lectures and being fully equipped to engage in discussions, background material will be provided online in the form of prerecorded lectures, knowledge clips and literature. Students registered to the course will study this material beforehand, and are monitored, i.e. using quizzes, in their progress.

The course is mainly intended for PhD students and junior post-docs. However, second year master students with a strong motivation to pursue a PhD in neuroscience may attend.


Supported by:


European Graduate School of Neuroscience (EURON)
University of Crete, Faculty of Medicine, Heraklion, Crete, Greece
University College Cork, Cork, Ireland
University of Minho, School of Medicine, Braga, Portugal